Improving access to effective addiction treatment
Substance use and addiction can result in fundamental changes in neurobiology and cognition. David Fiellin's research on opioid, alcohol, and tobacco use disorder uses techniques ranging from clinical trials to implementation science to help identify optimal strategies to improve access to and the quality of substance use and addiction prevention and treatment services. This often involves a combination of behavioral (contingency management, cognitive behavioral therapy) and pharmacologic treatments, as well as addressing co-occurring conditions beyond substance use that impact cognition, such as sleep and pain. This work increasingly involves neuroimaging and evaluating neural connections.
Methods
Topics
Biography
Fiellin thought he would pursue social science in college, but he gravitated toward biology instead. His work in addiction allows him to apply rigorous patient-oriented research methods learned as a Robert Wood Johnson Clinical Scholar at Yale to underserved populations. Fiellin thrives in multidisciplinary settings and has established the Program in Addiction Medicine to reflect this diversity.